




Analysis Type:	PANTHER Overrepresentation Test (Released 20230705)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.7942786 Released 2023-05-10
Analyzed List:	go-genelist-py-5.csv (Homo sapiens)go-genelist-r.csv (Homo sapiens)
Reference List:	Homo sapiens (all genes in database)
Test Type:	FISHER
Correction:	NONE
GO biological process complete	Homo sapiens - REFLIST (20589)	go-genelist-py-5.csv (113)	go-genelist-py-5.csv (expected)	go-genelist-py-5.csv (over/under)	go-genelist-py-5.csv (fold Enrichment)	go-genelist-py-5.csv (raw P-value)	go-genelist-r.csv (142)	go-genelist-r.csv (expected)	go-genelist-r.csv (over/under)	go-genelist-r.csv (fold Enrichment)	go-genelist-r.csv (raw P-value)
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
rhombomere 5 formation (GO:0021666)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere 5 structural organization (GO:0021665)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere 5 morphogenesis (GO:0021664)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere 3 formation (GO:0021660)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere 3 structural organization (GO:0021659)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
dibenzo-p-dioxin catabolic process (GO:0019341)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
spleen trabecula formation (GO:0060345)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
antigen sampling in mucosal-associated lymphoid tissue (GO:0002404)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere structural organization (GO:0021595)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhombomere formation (GO:0021594)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
nicotinamide metabolic process (GO:0006769)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
endothelial cell activation involved in immune response (GO:0002264)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
protein amidation (GO:0018032)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
ethylene metabolic process (GO:0009692)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
desmosome disassembly (GO:0035921)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
positive regulation of L-glutamine import across plasma membrane (GO:1901036)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
regulation of L-glutamine import across plasma membrane (GO:1901034)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
insecticide metabolic process (GO:0017143)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
negative regulation of protein localization to nucleolus (GO:1904750)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
rhythmic excitation (GO:0043179)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
fatty acid primary amide metabolic process (GO:0062126)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
fatty acid primary amide biosynthetic process (GO:0062112)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
iron ion export across plasma membrane (GO:1903988)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
protein kinase C deactivation (GO:0042313)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
positive regulation of autophagic cell death (GO:1904094)	1	1	.01	+	 > 100	1.09E-02	0	.01	-	 < 0.01	1.00E00
male courtship behavior (GO:0008049)	1	1	.01	+	 > 100	1.09E-02	1	.01	+	 > 100	1.37E-02
putrescine catabolic process (GO:0009447)	3	2	.02	+	 > 100	2.92E-04	2	.02	+	96.66	4.60E-04
positive regulation of detection of glucose (GO:2000972)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
regulation of detection of glucose (GO:2000970)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
rhombomere 3 morphogenesis (GO:0021658)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
dATP catabolic process (GO:0046061)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class II (GO:0002491)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
rhombomere morphogenesis (GO:0021593)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
keratinocyte activation (GO:0032980)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
positive regulation of glutamine transport (GO:2000487)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
cellular response to human chorionic gonadotropin stimulus (GO:0044751)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
epidermal growth factor receptor ligand maturation (GO:0038004)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
positive regulation of Schwann cell differentiation (GO:0014040)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
peptide amidation (GO:0001519)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
negative regulation of CD40 signaling pathway (GO:2000349)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
negative regulation of hematopoietic stem cell proliferation (GO:1902034)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
dGTP catabolic process (GO:0006203)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
slow endocytic recycling (GO:0032458)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
negative regulation of osteoclast proliferation (GO:0090291)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
asymmetric Golgi ribbon formation (GO:0090164)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
B cell receptor apoptotic signaling pathway (GO:1990117)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
olefin metabolic process (GO:1900673)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
cellular alkene metabolic process (GO:0043449)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
amino acid import (GO:0043090)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
pyridoxine biosynthetic process (GO:0008615)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
pyridoxine metabolic process (GO:0008614)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
cell-cell junction disassembly (GO:0150147)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
adaptation of rhodopsin mediated signaling (GO:0016062)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	2	1	.01	+	91.10	1.63E-02	0	.01	-	 < 0.01	1.00E00
tolerance induction to lipopolysaccharide (GO:0072573)	2	1	.01	+	91.10	1.63E-02	1	.01	+	72.50	2.04E-02
endoplasmic reticulum tubular network formation (GO:0071787)	5	2	.03	+	72.88	6.09E-04	0	.03	-	 < 0.01	1.00E00
plasma cell differentiation (GO:0002317)	5	2	.03	+	72.88	6.09E-04	2	.03	+	58.00	9.57E-04
polyamine catabolic process (GO:0006598)	5	2	.03	+	72.88	6.09E-04	2	.03	+	58.00	9.57E-04
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
dibenzo-p-dioxin metabolic process (GO:0018894)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
cell adhesion molecule production (GO:0060352)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
dGTP metabolic process (GO:0046070)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
dATP metabolic process (GO:0046060)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
myeloid dendritic cell antigen processing and presentation (GO:0002469)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
rhombomere 5 development (GO:0021571)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
rhombomere 3 development (GO:0021569)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
maternal process involved in parturition (GO:0060137)	6	2	.03	+	60.73	8.09E-04	0	.04	-	 < 0.01	1.00E00
spermidine acetylation (GO:0032918)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
polyamine acetylation (GO:0032917)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
striated muscle myosin thick filament assembly (GO:0071688)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
rhythmic synaptic transmission (GO:0060024)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
regulation of glutamine transport (GO:2000485)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
regulation of Schwann cell differentiation (GO:0014038)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
negative regulation of rRNA processing (GO:2000233)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
sarcomerogenesis (GO:0048769)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
negative regulation of activation-induced cell death of T cells (GO:0070236)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
endothelin receptor signaling pathway involved in heart process (GO:0086101)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
brain segmentation (GO:0035284)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
response to prostaglandin F (GO:0034696)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
skeletal muscle myosin thick filament assembly (GO:0030241)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
cellular response to rapamycin (GO:0072752)	3	1	.02	+	60.73	2.17E-02	0	.02	-	 < 0.01	1.00E00
courtship behavior (GO:0007619)	3	1	.02	+	60.73	2.17E-02	1	.02	+	48.33	2.71E-02
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	8	2	.04	+	45.55	1.29E-03	2	.06	+	36.25	2.02E-03
amino disaccharide catabolic process (GO:0052782)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
regulation of apoptotic process in bone marrow cell (GO:0071865)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
response to iron(III) ion (GO:0010041)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
positive regulation of sarcomere organization (GO:0060298)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
B-1 B cell homeostasis (GO:0001922)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
lymphocyte anergy (GO:0002249)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
response to Gram-positive bacterium (GO:0140459)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
positive regulation of L-glutamate import across plasma membrane (GO:0002038)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
cell wall disruption in another organism (GO:0044278)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
polysaccharide digestion (GO:0044245)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
protein K33-linked deubiquitination (GO:1990168)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
regulation of activation-induced cell death of T cells (GO:0070235)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
light adaption (GO:0036367)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
9-cis-retinoic acid metabolic process (GO:0042905)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
9-cis-retinoic acid biosynthetic process (GO:0042904)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
negative regulation of vesicle fusion (GO:0031339)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
myosin filament assembly (GO:0031034)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
central nervous system segmentation (GO:0035283)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
sympathetic neuron axon guidance (GO:0097492)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
dermatan sulfate catabolic process (GO:0030209)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
chondroitin sulfate catabolic process (GO:0030207)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
regulation of autophagic cell death (GO:1904092)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
nitric oxide transport (GO:0030185)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
meiotic cell cycle process involved in oocyte maturation (GO:1903537)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
T cell anergy (GO:0002870)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
vein smooth muscle contraction (GO:0014826)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
cell migration involved in endocardial cushion formation (GO:0003273)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
L-kynurenine catabolic process (GO:0097053)	4	1	.02	+	45.55	2.70E-02	1	.03	+	36.25	3.38E-02
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	4	1	.02	+	45.55	2.70E-02	0	.03	-	 < 0.01	1.00E00
putrescine metabolic process (GO:0009445)	9	2	.05	+	40.49	1.57E-03	2	.06	+	32.22	2.46E-03
negative regulation of amyloid-beta clearance (GO:1900222)	9	2	.05	+	40.49	1.57E-03	0	.06	-	 < 0.01	1.00E00
negative regulation of chronic inflammatory response (GO:0002677)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
positive regulation of T cell anergy (GO:0002669)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
odontoblast differentiation (GO:0071895)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
male mating behavior (GO:0060179)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
response to human chorionic gonadotropin (GO:0044752)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
protein retention in Golgi apparatus (GO:0045053)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
Golgi reassembly (GO:0090168)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
response to herbicide (GO:0009635)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
renal sodium ion absorption (GO:0070294)	10	2	.05	+	36.44	1.88E-03	1	.07	+	14.50	7.28E-02
vitamin B6 metabolic process (GO:0042816)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
protein K29-linked deubiquitination (GO:0035523)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
positive regulation of TORC2 signaling (GO:1904515)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
myosin filament organization (GO:0031033)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
purine nucleoside triphosphate catabolic process (GO:0009146)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
ectodermal cell differentiation (GO:0010668)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
membrane to membrane docking (GO:0022614)	5	1	.03	+	36.44	3.23E-02	1	.03	+	29.00	4.04E-02
positive regulation of lymphocyte anergy (GO:0002913)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)	10	2	.05	+	36.44	1.88E-03	1	.07	+	14.50	7.28E-02
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	5	1	.03	+	36.44	3.23E-02	0	.03	-	 < 0.01	1.00E00
peptide antigen assembly with MHC class II protein complex (GO:0002503)	17	3	.09	+	32.15	1.69E-04	0	.12	-	 < 0.01	1.00E00
MHC class II protein complex assembly (GO:0002399)	17	3	.09	+	32.15	1.69E-04	0	.12	-	 < 0.01	1.00E00
response to ozone (GO:0010193)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
T cell tolerance induction (GO:0002517)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
positive regulation of type II interferon-mediated signaling pathway (GO:0060335)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
positive regulation of response to type II interferon (GO:0060332)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
negative regulation of respiratory burst (GO:0060268)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
L-serine biosynthetic process (GO:0006564)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
neural crest cell fate commitment (GO:0014034)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
regulation of CD40 signaling pathway (GO:2000348)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
cellular response to luteinizing hormone stimulus (GO:0071373)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
regulation of osteoclast proliferation (GO:0090289)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
response to rapamycin (GO:1901355)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
negative regulation of monocyte chemotaxis (GO:0090027)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
response to symbiotic bacterium (GO:0009609)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
response to symbiont (GO:0009608)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
gamma-aminobutyric acid biosynthetic process (GO:0009449)	6	1	.03	+	30.37	3.76E-02	2	.04	+	48.33	1.27E-03
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
regulation of TORC2 signaling (GO:1903939)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
positive regulation of odontogenesis (GO:0042482)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
rhodopsin mediated signaling pathway (GO:0016056)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
response to cisplatin (GO:0072718)	6	1	.03	+	30.37	3.76E-02	1	.04	+	24.17	4.70E-02
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	6	1	.03	+	30.37	3.76E-02	0	.04	-	 < 0.01	1.00E00
renal sodium ion transport (GO:0003096)	13	2	.07	+	28.03	2.96E-03	1	.09	+	11.15	9.18E-02
cellular response to mineralocorticoid stimulus (GO:0071389)	13	2	.07	+	28.03	2.96E-03	1	.09	+	11.15	9.18E-02
nucleoside triphosphate catabolic process (GO:0009143)	13	2	.07	+	28.03	2.96E-03	1	.09	+	11.15	9.18E-02
amine catabolic process (GO:0009310)	20	3	.11	+	27.33	2.59E-04	3	.14	+	21.75	5.04E-04
cellular biogenic amine catabolic process (GO:0042402)	20	3	.11	+	27.33	2.59E-04	3	.14	+	21.75	5.04E-04
negative regulation of vitamin metabolic process (GO:0046137)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
activation-induced cell death of T cells (GO:0006924)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
peptide antigen assembly with MHC protein complex (GO:0002501)	21	3	.12	+	26.03	2.95E-04	0	.14	-	 < 0.01	1.00E00
rhombomere development (GO:0021546)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
regulation of sarcomere organization (GO:0060297)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
regulation of respiratory burst involved in inflammatory response (GO:0060264)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
MHC protein complex assembly (GO:0002396)	21	3	.12	+	26.03	2.95E-04	0	.14	-	 < 0.01	1.00E00
DNA strand resection involved in replication fork processing (GO:0110025)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
histamine secretion (GO:0001821)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
ganglioside catabolic process (GO:0006689)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
regulation of mitochondrial mRNA stability (GO:0044528)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
regulation of ribosome biogenesis (GO:0090069)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
hydrocarbon metabolic process (GO:0120252)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
astrocyte cell migration (GO:0043615)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
maintenance of lens transparency (GO:0036438)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
detection of muscle stretch (GO:0035995)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
response to nematode (GO:0009624)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
interleukin-27-mediated signaling pathway (GO:0070106)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
response to insecticide (GO:0017085)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
protein import into peroxisome matrix, receptor recycling (GO:0016562)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
ribosomal small subunit export from nucleus (GO:0000056)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
autocrine signaling (GO:0035425)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
positive regulation of protein kinase C activity (GO:1900020)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
regulation of protein kinase C activity (GO:1900019)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
receptor-mediated virion attachment to host cell (GO:0046813)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
negative regulation of p38MAPK cascade (GO:1903753)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
skeletal muscle thin filament assembly (GO:0030240)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
pancreatic juice secretion (GO:0030157)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
lipid hydroxylation (GO:0002933)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
L-kynurenine metabolic process (GO:0097052)	7	1	.04	+	26.03	4.28E-02	1	.05	+	20.71	5.35E-02
regulation of vitamin D biosynthetic process (GO:0060556)	7	1	.04	+	26.03	4.28E-02	0	.05	-	 < 0.01	1.00E00
regulation of T cell anergy (GO:0002667)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
regulation of germinal center formation (GO:0002634)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
facial nerve structural organization (GO:0021612)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
cobalt ion transport (GO:0006824)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
diacylglycerol biosynthetic process (GO:0006651)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
regulation of L-glutamate import across plasma membrane (GO:0002036)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
positive regulation of T-helper 17 cell differentiation (GO:2000321)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
cellular response to ether (GO:0071362)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
alkaloid metabolic process (GO:0009820)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
coumarin metabolic process (GO:0009804)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
activated T cell proliferation (GO:0050798)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
phenylpropanoid metabolic process (GO:0009698)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	8	1	.04	+	22.78	4.81E-02	2	.06	+	36.25	2.02E-03
hepatocyte growth factor receptor signaling pathway (GO:0048012)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
peptide modification (GO:0031179)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
preassembly of GPI anchor in ER membrane (GO:0016254)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
water-soluble vitamin biosynthetic process (GO:0042364)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
response to luteinizing hormone (GO:0034699)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
cellular response to aldosterone (GO:1904045)	8	1	.04	+	22.78	4.81E-02	1	.06	+	18.12	6.00E-02
regulation of lymphocyte anergy (GO:0002911)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	8	1	.04	+	22.78	4.81E-02	0	.06	-	 < 0.01	1.00E00
parturition (GO:0007567)	16	2	.09	+	22.78	4.27E-03	0	.11	-	 < 0.01	1.00E00
cellular response to aldehyde (GO:0110096)	17	2	.09	+	21.44	4.75E-03	2	.12	+	17.06	7.38E-03
endoplasmic reticulum tubular network organization (GO:0071786)	17	2	.09	+	21.44	4.75E-03	0	.12	-	 < 0.01	1.00E00
toxin metabolic process (GO:0009404)	17	2	.09	+	21.44	4.75E-03	1	.12	+	8.53	1.16E-01
cell migration involved in heart development (GO:0060973)	17	2	.09	+	21.44	4.75E-03	0	.12	-	 < 0.01	1.00E00
regulation of amino acid import across plasma membrane (GO:0010958)	18	2	.10	+	20.24	5.26E-03	1	.12	+	8.06	1.22E-01
regulation of amino acid transmembrane transport (GO:1903789)	18	2	.10	+	20.24	5.26E-03	1	.12	+	8.06	1.22E-01
tolerance induction (GO:0002507)	19	2	.10	+	19.18	5.80E-03	1	.13	+	7.63	1.28E-01
regulation of amyloid-beta clearance (GO:1900221)	19	2	.10	+	19.18	5.80E-03	0	.13	-	 < 0.01	1.00E00
ribosomal small subunit assembly (GO:0000028)	19	2	.10	+	19.18	5.80E-03	1	.13	+	7.63	1.28E-01
polyamine metabolic process (GO:0006595)	20	2	.11	+	18.22	6.35E-03	2	.14	+	14.50	9.84E-03
response to muramyl dipeptide (GO:0032495)	20	2	.11	+	18.22	6.35E-03	2	.14	+	14.50	9.84E-03
protein kinase A signaling (GO:0010737)	20	2	.11	+	18.22	6.35E-03	1	.14	+	7.25	1.34E-01
ceramide catabolic process (GO:0046514)	20	2	.11	+	18.22	6.35E-03	2	.14	+	14.50	9.84E-03
pyridine-containing compound biosynthetic process (GO:0072525)	31	3	.17	+	17.63	8.38E-04	2	.21	+	9.35	2.14E-02
glycogen biosynthetic process (GO:0005978)	21	2	.12	+	17.35	6.93E-03	1	.14	+	6.90	1.40E-01
glucan biosynthetic process (GO:0009250)	21	2	.12	+	17.35	6.93E-03	1	.14	+	6.90	1.40E-01
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	32	3	.18	+	17.08	9.13E-04	1	.22	+	4.53	2.03E-01
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	34	3	.19	+	16.08	1.07E-03	1	.23	+	4.26	2.14E-01
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	35	3	.19	+	15.62	1.16E-03	1	.24	+	4.14	2.19E-01
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	24	2	.13	+	15.18	8.81E-03	0	.17	-	 < 0.01	1.00E00
positive regulation of amino acid transport (GO:0051957)	25	2	.14	+	14.58	9.48E-03	1	.17	+	5.80	1.64E-01
NAD biosynthetic process (GO:0009435)	25	2	.14	+	14.58	9.48E-03	1	.17	+	5.80	1.64E-01
response to muscle stretch (GO:0035994)	26	2	.14	+	14.02	1.02E-02	2	.18	+	11.15	1.57E-02
retinol metabolic process (GO:0042572)	53	4	.29	+	13.75	2.66E-04	3	.37	+	8.21	6.69E-03
pyridine nucleotide biosynthetic process (GO:0019363)	27	2	.15	+	13.50	1.09E-02	1	.19	+	5.37	1.75E-01
nicotinamide nucleotide biosynthetic process (GO:0019359)	27	2	.15	+	13.50	1.09E-02	1	.19	+	5.37	1.75E-01
innervation (GO:0060384)	27	2	.15	+	13.50	1.09E-02	1	.19	+	5.37	1.75E-01
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	41	3	.23	+	13.33	1.78E-03	1	.28	+	3.54	2.51E-01
chronic inflammatory response (GO:0002544)	14	1	.08	+	13.01	7.88E-02	3	.10	+	31.07	1.99E-04
mature B cell differentiation involved in immune response (GO:0002313)	28	2	.15	+	13.01	1.16E-02	2	.19	+	10.36	1.79E-02
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	14	1	.08	+	13.01	7.88E-02	2	.10	+	20.71	5.25E-03
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	29	2	.16	+	12.57	1.24E-02	1	.20	+	5.00	1.86E-01
renal absorption (GO:0070293)	29	2	.16	+	12.57	1.24E-02	2	.20	+	10.00	1.90E-02
negative regulation of endothelial cell apoptotic process (GO:2000352)	30	2	.16	+	12.15	1.32E-02	1	.21	+	4.83	1.92E-01
isoprenoid biosynthetic process (GO:0008299)	30	2	.16	+	12.15	1.32E-02	1	.21	+	4.83	1.92E-01
sphingolipid catabolic process (GO:0030149)	30	2	.16	+	12.15	1.32E-02	2	.21	+	9.67	2.02E-02
response to iron ion (GO:0010039)	31	2	.17	+	11.76	1.40E-02	0	.21	-	 < 0.01	1.00E00
glycolipid catabolic process (GO:0019377)	16	1	.09	+	11.39	8.89E-02	2	.11	+	18.12	6.63E-03
lipid digestion (GO:0044241)	16	1	.09	+	11.39	8.89E-02	2	.11	+	18.12	6.63E-03
retinoic acid metabolic process (GO:0042573)	32	2	.18	+	11.39	1.48E-02	1	.22	+	4.53	2.03E-01
positive regulation of organic acid transport (GO:0032892)	49	3	.27	+	11.16	2.88E-03	1	.34	+	2.96	2.91E-01
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	33	2	.18	+	11.04	1.56E-02	1	.23	+	4.39	2.09E-01
establishment of skin barrier (GO:0061436)	33	2	.18	+	11.04	1.56E-02	2	.23	+	8.79	2.39E-02
establishment of endothelial barrier (GO:0061028)	33	2	.18	+	11.04	1.56E-02	0	.23	-	 < 0.01	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	50	3	.27	+	10.93	3.04E-03	1	.34	+	2.90	2.96E-01
retinoid metabolic process (GO:0001523)	85	5	.47	+	10.72	1.35E-04	3	.59	+	5.12	2.26E-02
protein export from nucleus (GO:0006611)	34	2	.19	+	10.72	1.65E-02	0	.23	-	 < 0.01	1.00E00
protein K63-linked deubiquitination (GO:0070536)	34	2	.19	+	10.72	1.65E-02	2	.23	+	8.53	2.52E-02
polysaccharide biosynthetic process (GO:0000271)	34	2	.19	+	10.72	1.65E-02	1	.23	+	4.26	2.14E-01
mature B cell differentiation (GO:0002335)	35	2	.19	+	10.41	1.74E-02	2	.24	+	8.29	2.65E-02
peroxisome organization (GO:0007031)	35	2	.19	+	10.41	1.74E-02	2	.24	+	8.29	2.65E-02
diterpenoid metabolic process (GO:0016101)	88	5	.48	+	10.35	1.57E-04	3	.61	+	4.94	2.47E-02
astrocyte development (GO:0014002)	36	2	.20	+	10.12	1.83E-02	1	.25	+	4.03	2.25E-01
regulation of amyloid-beta formation (GO:1902003)	36	2	.20	+	10.12	1.83E-02	0	.25	-	 < 0.01	1.00E00
membrane lipid catabolic process (GO:0046466)	36	2	.20	+	10.12	1.83E-02	3	.25	+	12.08	2.40E-03
negative regulation of anoikis (GO:2000811)	19	1	.10	+	9.59	1.04E-01	2	.13	+	15.26	8.98E-03
sarcomere organization (GO:0045214)	38	2	.21	+	9.59	2.01E-02	1	.26	+	3.82	2.35E-01
response to mineralocorticoid (GO:0051385)	38	2	.21	+	9.59	2.01E-02	1	.26	+	3.82	2.35E-01
spleen development (GO:0048536)	38	2	.21	+	9.59	2.01E-02	1	.26	+	3.82	2.35E-01
lymphocyte apoptotic process (GO:0070227)	38	2	.21	+	9.59	2.01E-02	1	.26	+	3.82	2.35E-01
isoprenoid metabolic process (GO:0006720)	135	7	.74	+	9.45	1.30E-05	5	.93	+	5.37	2.80E-03
terpenoid metabolic process (GO:0006721)	99	5	.54	+	9.20	2.65E-04	3	.68	+	4.39	3.30E-02
amine metabolic process (GO:0009308)	99	5	.54	+	9.20	2.65E-04	4	.68	+	5.86	5.53E-03
mitophagy (GO:0000423)	20	1	.11	+	9.11	1.09E-01	2	.14	+	14.50	9.84E-03
ribosome assembly (GO:0042255)	61	3	.33	+	8.96	5.18E-03	2	.42	+	4.75	6.94E-02
regulation of T-helper cell differentiation (GO:0045622)	41	2	.23	+	8.89	2.31E-02	1	.28	+	3.54	2.51E-01
acute-phase response (GO:0006953)	42	2	.23	+	8.68	2.41E-02	2	.29	+	6.90	3.65E-02
syncytium formation (GO:0006949)	42	2	.23	+	8.68	2.41E-02	0	.29	-	 < 0.01	1.00E00
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	42	2	.23	+	8.68	2.41E-02	1	.29	+	3.45	2.56E-01
somatic diversification of immunoglobulins (GO:0016445)	42	2	.23	+	8.68	2.41E-02	1	.29	+	3.45	2.56E-01
NAD metabolic process (GO:0019674)	42	2	.23	+	8.68	2.41E-02	1	.29	+	3.45	2.56E-01
positive regulation of amine transport (GO:0051954)	43	2	.24	+	8.47	2.51E-02	1	.30	+	3.37	2.61E-01
response to copper ion (GO:0046688)	43	2	.24	+	8.47	2.51E-02	1	.30	+	3.37	2.61E-01
regulation of amyloid precursor protein catabolic process (GO:1902991)	43	2	.24	+	8.47	2.51E-02	0	.30	-	 < 0.01	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	65	3	.36	+	8.41	6.13E-03	4	.45	+	8.92	1.29E-03
response to dexamethasone (GO:0071548)	44	2	.24	+	8.28	2.61E-02	3	.30	+	9.89	4.09E-03
regulation of amino acid transport (GO:0051955)	44	2	.24	+	8.28	2.61E-02	1	.30	+	3.30	2.66E-01
digestion (GO:0007586)	112	5	.61	+	8.13	4.57E-04	3	.77	+	3.88	4.46E-02
biogenic amine metabolic process (GO:0006576)	90	4	.49	+	8.10	1.76E-03	3	.62	+	4.83	2.61E-02
regulation of keratinocyte proliferation (GO:0010837)	45	2	.25	+	8.10	2.72E-02	1	.31	+	3.22	2.71E-01
catecholamine metabolic process (GO:0006584)	46	2	.25	+	7.92	2.83E-02	1	.32	+	3.15	2.76E-01
catechol-containing compound metabolic process (GO:0009712)	46	2	.25	+	7.92	2.83E-02	1	.32	+	3.15	2.76E-01
regulation of defense response to virus by host (GO:0050691)	47	2	.26	+	7.75	2.94E-02	2	.32	+	6.17	4.44E-02
lymphocyte homeostasis (GO:0002260)	71	3	.39	+	7.70	7.75E-03	1	.49	+	2.04	3.91E-01
antigen processing and presentation of peptide antigen (GO:0048002)	71	3	.39	+	7.70	7.75E-03	1	.49	+	2.04	3.91E-01
leukocyte apoptotic process (GO:0071887)	48	2	.26	+	7.59	3.05E-02	1	.33	+	3.02	2.86E-01
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	48	2	.26	+	7.59	3.05E-02	3	.33	+	9.06	5.15E-03
primary alcohol metabolic process (GO:0034308)	96	4	.53	+	7.59	2.21E-03	3	.66	+	4.53	3.06E-02
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	98	4	.54	+	7.44	2.37E-03	3	.68	+	4.44	3.22E-02
antiviral innate immune response (GO:0140374)	49	2	.27	+	7.44	3.16E-02	1	.34	+	2.96	2.91E-01
regulation of endothelial cell apoptotic process (GO:2000351)	49	2	.27	+	7.44	3.16E-02	2	.34	+	5.92	4.78E-02
axon extension (GO:0048675)	49	2	.27	+	7.44	3.16E-02	1	.34	+	2.96	2.91E-01
intermediate filament organization (GO:0045109)	74	3	.41	+	7.39	8.64E-03	2	.51	+	3.92	9.57E-02
body fluid secretion (GO:0007589)	74	3	.41	+	7.39	8.64E-03	2	.51	+	3.92	9.57E-02
endothelial cell development (GO:0001885)	50	2	.27	+	7.29	3.28E-02	0	.34	-	 < 0.01	1.00E00
secondary metabolic process (GO:0019748)	50	2	.27	+	7.29	3.28E-02	1	.34	+	2.90	2.96E-01
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	76	3	.42	+	7.19	9.27E-03	1	.52	+	1.91	4.12E-01
positive regulation of alpha-beta T cell differentiation (GO:0046638)	51	2	.28	+	7.15	3.40E-02	1	.35	+	2.84	3.01E-01
regulation of granulocyte chemotaxis (GO:0071622)	52	2	.29	+	7.01	3.51E-02	2	.36	+	5.58	5.29E-02
somatic diversification of immune receptors (GO:0002200)	52	2	.29	+	7.01	3.51E-02	1	.36	+	2.79	3.06E-01
regulation of anoikis (GO:2000209)	26	1	.14	+	7.01	1.37E-01	2	.18	+	11.15	1.57E-02
positive regulation of TOR signaling (GO:0032008)	52	2	.29	+	7.01	3.51E-02	2	.36	+	5.58	5.29E-02
pyridine-containing compound metabolic process (GO:0072524)	79	3	.43	+	6.92	1.03E-02	2	.54	+	3.67	1.06E-01
regulation of organic acid transport (GO:0032890)	80	3	.44	+	6.83	1.06E-02	2	.55	+	3.62	1.09E-01
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	54	2	.30	+	6.75	3.76E-02	3	.37	+	8.06	7.03E-03
response to vitamin (GO:0033273)	81	3	.44	+	6.75	1.10E-02	2	.56	+	3.58	1.11E-01
glycogen metabolic process (GO:0005977)	54	2	.30	+	6.75	3.76E-02	1	.37	+	2.69	3.15E-01
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	54	2	.30	+	6.75	3.76E-02	1	.37	+	2.69	3.15E-01
respiratory gaseous exchange by respiratory system (GO:0007585)	54	2	.30	+	6.75	3.76E-02	2	.37	+	5.37	5.64E-02
cellular response to type II interferon (GO:0071346)	109	4	.60	+	6.69	3.43E-03	2	.75	+	2.66	1.76E-01
cellular response to glucocorticoid stimulus (GO:0071385)	55	2	.30	+	6.63	3.88E-02	3	.38	+	7.91	7.37E-03
leukocyte cell-cell adhesion (GO:0007159)	56	2	.31	+	6.51	4.00E-02	1	.39	+	2.59	3.25E-01
glutamine metabolic process (GO:0006541)	28	1	.15	+	6.51	1.47E-01	3	.19	+	15.53	1.23E-03
cellular response to dexamethasone stimulus (GO:0071549)	28	1	.15	+	6.51	1.47E-01	3	.19	+	15.53	1.23E-03
glucan metabolic process (GO:0044042)	56	2	.31	+	6.51	4.00E-02	1	.39	+	2.59	3.25E-01
neurotransmitter metabolic process (GO:0042133)	28	1	.15	+	6.51	1.47E-01	2	.19	+	10.36	1.79E-02
B cell activation involved in immune response (GO:0002312)	57	2	.31	+	6.39	4.13E-02	2	.39	+	5.09	6.19E-02
negative regulation of innate immune response (GO:0045824)	86	3	.47	+	6.36	1.28E-02	2	.59	+	3.37	1.22E-01
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	58	2	.32	+	6.28	4.26E-02	1	.40	+	2.50	3.34E-01
water-soluble vitamin metabolic process (GO:0006767)	58	2	.32	+	6.28	4.26E-02	2	.40	+	5.00	6.37E-02
negative regulation of MAP kinase activity (GO:0043407)	58	2	.32	+	6.28	4.26E-02	1	.40	+	2.50	3.34E-01
negative regulation of response to wounding (GO:1903035)	88	3	.48	+	6.21	1.36E-02	2	.61	+	3.30	1.27E-01
negative regulation of epithelial cell apoptotic process (GO:1904036)	59	2	.32	+	6.18	4.39E-02	1	.41	+	2.46	3.38E-01
cardiac muscle hypertrophy (GO:0003300)	30	1	.16	+	6.07	1.56E-01	2	.21	+	9.67	2.02E-02
cellular response to hydrogen peroxide (GO:0070301)	62	2	.34	+	5.88	4.78E-02	1	.43	+	2.34	3.52E-01
striated muscle hypertrophy (GO:0014897)	31	1	.17	+	5.88	1.61E-01	2	.21	+	9.35	2.14E-02
nerve development (GO:0021675)	93	3	.51	+	5.88	1.57E-02	1	.64	+	1.56	4.77E-01
intermediate filament cytoskeleton organization (GO:0045104)	94	3	.52	+	5.82	1.61E-02	2	.65	+	3.08	1.41E-01
defense response to Gram-negative bacterium (GO:0050829)	94	3	.52	+	5.82	1.61E-02	2	.65	+	3.08	1.41E-01
intermediate filament-based process (GO:0045103)	95	3	.52	+	5.75	1.66E-02	2	.66	+	3.05	1.43E-01
endoplasmic reticulum organization (GO:0007029)	96	3	.53	+	5.69	1.70E-02	1	.66	+	1.51	4.87E-01
chaperone cofactor-dependent protein refolding (GO:0051085)	32	1	.18	+	5.69	1.65E-01	3	.22	+	13.59	1.75E-03
leukocyte homeostasis (GO:0001776)	97	3	.53	+	5.64	1.75E-02	1	.67	+	1.49	4.91E-01
immune system development (GO:0002520)	165	5	.91	+	5.52	2.42E-03	2	1.14	+	1.76	3.17E-01
muscle hypertrophy (GO:0014896)	33	1	.18	+	5.52	1.70E-01	2	.23	+	8.79	2.39E-02
vitamin metabolic process (GO:0006766)	99	3	.54	+	5.52	1.84E-02	2	.68	+	2.93	1.52E-01
response to type II interferon (GO:0034341)	133	4	.73	+	5.48	6.78E-03	3	.92	+	3.27	6.69E-02
response to hydrogen peroxide (GO:0042542)	100	3	.55	+	5.47	1.89E-02	3	.69	+	4.35	3.39E-02
maintenance of location in cell (GO:0051651)	101	3	.55	+	5.41	1.94E-02	3	.70	+	4.31	3.47E-02
protein localization to endoplasmic reticulum (GO:0070972)	68	2	.37	+	5.36	5.61E-02	3	.47	+	6.40	1.28E-02
endothelium development (GO:0003158)	102	3	.56	+	5.36	1.99E-02	0	.70	-	 < 0.01	1.00E00
multi-multicellular organism process (GO:0044706)	205	6	1.13	+	5.33	1.07E-03	4	1.41	+	2.83	5.58E-02
cellular response to ketone (GO:1901655)	105	3	.58	+	5.21	2.14E-02	4	.72	+	5.52	6.74E-03
bicarbonate transport (GO:0015701)	35	1	.19	+	5.21	1.79E-01	2	.24	+	8.29	2.65E-02
antigen processing and presentation (GO:0019882)	105	3	.58	+	5.21	2.14E-02	1	.72	+	1.38	5.18E-01
regulation of signal transduction by p53 class mediator (GO:1901796)	107	3	.59	+	5.11	2.24E-02	2	.74	+	2.71	1.72E-01
reactive oxygen species metabolic process (GO:0072593)	108	3	.59	+	5.06	2.29E-02	3	.74	+	4.03	4.09E-02
DNA damage checkpoint signaling (GO:0000077)	109	3	.60	+	5.01	2.35E-02	0	.75	-	 < 0.01	1.00E00
olefinic compound metabolic process (GO:0120254)	146	4	.80	+	4.99	9.27E-03	4	1.01	+	3.97	1.98E-02
negative regulation of protein serine/threonine kinase activity (GO:0071901)	110	3	.60	+	4.97	2.40E-02	2	.76	+	2.64	1.79E-01
negative regulation of protein catabolic process (GO:0042177)	110	3	.60	+	4.97	2.40E-02	2	.76	+	2.64	1.79E-01
'de novo' post-translational protein folding (GO:0051084)	37	1	.20	+	4.92	1.88E-01	3	.26	+	11.76	2.58E-03
amino acid biosynthetic process (GO:0008652)	74	2	.41	+	4.92	6.48E-02	6	.51	+	11.76	1.84E-05
response to virus (GO:0009615)	372	10	2.04	+	4.90	4.68E-05	4	2.57	+	1.56	3.31E-01
ovulation cycle (GO:0042698)	75	2	.41	+	4.86	6.63E-02	3	.52	+	5.80	1.65E-02
regulation of cytokine-mediated signaling pathway (GO:0001959)	153	4	.84	+	4.76	1.08E-02	2	1.06	+	1.90	2.87E-01
cellular component assembly involved in morphogenesis (GO:0010927)	115	3	.63	+	4.75	2.69E-02	1	.79	+	1.26	5.50E-01
regulation of alpha-beta T cell activation (GO:0046634)	115	3	.63	+	4.75	2.69E-02	2	.79	+	2.52	1.91E-01
defense response to virus (GO:0051607)	270	7	1.48	+	4.72	8.22E-04	3	1.86	+	1.61	4.39E-01
regulation of TOR signaling (GO:0032006)	116	3	.64	+	4.71	2.75E-02	3	.80	+	3.75	4.85E-02
actomyosin structure organization (GO:0031032)	116	3	.64	+	4.71	2.75E-02	2	.80	+	2.50	1.94E-01
defense response to symbiont (GO:0140546)	271	7	1.49	+	4.71	8.40E-04	3	1.87	+	1.61	4.40E-01
one-carbon metabolic process (GO:0006730)	39	1	.21	+	4.67	1.97E-01	2	.27	+	7.44	3.21E-02
prostaglandin metabolic process (GO:0006693)	39	1	.21	+	4.67	1.97E-01	2	.27	+	7.44	3.21E-02
prostanoid metabolic process (GO:0006692)	39	1	.21	+	4.67	1.97E-01	2	.27	+	7.44	3.21E-02
multi-organism reproductive process (GO:0044703)	195	5	1.07	+	4.67	4.84E-03	3	1.34	+	2.23	1.55E-01
DNA integrity checkpoint signaling (GO:0031570)	118	3	.65	+	4.63	2.87E-02	0	.81	-	 < 0.01	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	158	4	.87	+	4.61	1.20E-02	4	1.09	+	3.67	2.54E-02
sensory perception of sound (GO:0007605)	159	4	.87	+	4.58	1.23E-02	1	1.10	-	.91	1.00E00
complement activation, classical pathway (GO:0006958)	40	1	.22	+	4.56	2.01E-01	2	.28	+	7.25	3.36E-02
regulation of response to wounding (GO:1903034)	163	4	.89	+	4.47	1.33E-02	6	1.12	+	5.34	1.10E-03
response to testosterone (GO:0033574)	41	1	.23	+	4.44	2.06E-01	2	.28	+	7.07	3.50E-02
'de novo' protein folding (GO:0006458)	41	1	.23	+	4.44	2.06E-01	3	.28	+	10.61	3.39E-03
regulation of response to cytokine stimulus (GO:0060759)	164	4	.90	+	4.44	1.36E-02	2	1.13	+	1.77	3.15E-01
positive regulation of protein ubiquitination (GO:0031398)	124	3	.68	+	4.41	3.24E-02	2	.86	+	2.34	2.14E-01
hormone metabolic process (GO:0042445)	208	5	1.14	+	4.38	6.29E-03	7	1.43	+	4.88	7.13E-04
lymphocyte proliferation (GO:0046651)	125	3	.69	+	4.37	3.31E-02	1	.86	+	1.16	5.80E-01
response to corticosteroid (GO:0031960)	167	4	.92	+	4.36	1.44E-02	5	1.15	+	4.34	6.67E-03
negative regulation of inflammatory response (GO:0050728)	167	4	.92	+	4.36	1.44E-02	4	1.15	+	3.47	3.02E-02
acute inflammatory response (GO:0002526)	85	2	.47	+	4.29	8.19E-02	3	.59	+	5.12	2.26E-02
regulation of leukocyte chemotaxis (GO:0002688)	128	3	.70	+	4.27	3.50E-02	3	.88	+	3.40	6.12E-02
mononuclear cell proliferation (GO:0032943)	129	3	.71	+	4.24	3.57E-02	1	.89	+	1.12	5.92E-01
regulation of wound healing (GO:0061041)	129	3	.71	+	4.24	3.57E-02	5	.89	+	5.62	2.31E-03
regulation of protein ubiquitination (GO:0031396)	216	5	1.19	+	4.22	7.33E-03	4	1.49	+	2.69	6.49E-02
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	44	1	.24	+	4.14	2.19E-01	2	.30	+	6.59	3.96E-02
regulation of bone resorption (GO:0045124)	44	1	.24	+	4.14	2.19E-01	2	.30	+	6.59	3.96E-02
negative regulation of response to biotic stimulus (GO:0002832)	133	3	.73	+	4.11	3.85E-02	2	.92	+	2.18	2.36E-01
vesicle-mediated transport to the plasma membrane (GO:0098876)	134	3	.74	+	4.08	3.92E-02	1	.92	+	1.08	6.06E-01
nuclear export (GO:0051168)	134	3	.74	+	4.08	3.92E-02	0	.92	-	 < 0.01	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	45	1	.25	+	4.05	2.23E-01	2	.31	+	6.44	4.12E-02
response to pH (GO:0009268)	45	1	.25	+	4.05	2.23E-01	2	.31	+	6.44	4.12E-02
lymphocyte activation involved in immune response (GO:0002285)	136	3	.75	+	4.02	4.07E-02	3	.94	+	3.20	7.05E-02
response to hypoxia (GO:0001666)	272	6	1.49	+	4.02	4.24E-03	6	1.88	+	3.20	1.24E-02
sensory perception of mechanical stimulus (GO:0050954)	182	4	1.00	+	4.00	1.90E-02	1	1.26	-	.80	1.00E00
protein-containing complex disassembly (GO:0032984)	139	3	.76	+	3.93	4.29E-02	3	.96	+	3.13	7.41E-02
mRNA transcription by RNA polymerase II (GO:0042789)	47	1	.26	+	3.88	2.31E-01	2	.32	+	6.17	4.44E-02
signal transduction in response to DNA damage (GO:0042770)	142	3	.78	+	3.85	4.51E-02	1	.98	+	1.02	6.27E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	142	3	.78	+	3.85	4.51E-02	2	.98	+	2.04	2.59E-01
response to glucocorticoid (GO:0051384)	143	3	.78	+	3.82	4.59E-02	4	.99	+	4.06	1.86E-02
response to decreased oxygen levels (GO:0036293)	286	6	1.57	+	3.82	5.37E-03	6	1.97	+	3.04	1.54E-02
Golgi organization (GO:0007030)	144	3	.79	+	3.80	4.67E-02	1	.99	+	1.01	1.00E00
regulation of signaling receptor activity (GO:0010469)	144	3	.79	+	3.80	4.67E-02	0	.99	-	 < 0.01	6.30E-01
negative regulation of coagulation (GO:0050819)	49	1	.27	+	3.72	2.40E-01	2	.34	+	5.92	4.78E-02
negative regulation of epithelial cell differentiation (GO:0030857)	49	1	.27	+	3.72	2.40E-01	3	.34	+	8.88	5.44E-03
leukocyte migration (GO:0050900)	246	5	1.35	+	3.70	1.23E-02	3	1.70	+	1.77	2.43E-01
leukocyte proliferation (GO:0070661)	148	3	.81	+	3.69	4.98E-02	1	1.02	-	.98	1.00E00
negative regulation of immune response (GO:0050777)	198	4	1.09	+	3.68	2.49E-02	2	1.37	+	1.46	3.99E-01
protein-RNA complex assembly (GO:0022618)	199	4	1.09	+	3.66	2.53E-02	2	1.37	+	1.46	4.01E-01
negative regulation of protein kinase activity (GO:0006469)	200	4	1.10	+	3.64	2.57E-02	2	1.38	+	1.45	4.04E-01
DNA replication (GO:0006260)	200	4	1.10	+	3.64	2.57E-02	1	1.38	-	.72	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	200	4	1.10	+	3.64	2.57E-02	4	1.38	+	2.90	5.19E-02
regulation of gluconeogenesis (GO:0006111)	50	1	.27	+	3.64	2.44E-01	2	.34	+	5.80	4.94E-02
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	50	1	.27	+	3.64	2.44E-01	2	.34	+	5.80	4.94E-02
positive regulation of T cell activation (GO:0050870)	251	5	1.38	+	3.63	1.32E-02	4	1.73	+	2.31	9.84E-02
response to nutrient (GO:0007584)	152	3	.83	+	3.60	5.31E-02	4	1.05	+	3.82	2.25E-02
cellular response to metal ion (GO:0071248)	204	4	1.12	+	3.57	2.73E-02	1	1.41	-	.71	1.00E00
regulation of protein modification by small protein conjugation or removal (GO:1903320)	256	5	1.41	+	3.56	1.43E-02	4	1.77	+	2.27	1.04E-01
cell activation involved in immune response (GO:0002263)	205	4	1.13	+	3.56	2.77E-02	4	1.41	+	2.83	5.58E-02
response to heat (GO:0009408)	103	2	.57	+	3.54	1.12E-01	3	.71	+	4.22	3.64E-02
protein-RNA complex organization (GO:0071826)	207	4	1.14	+	3.52	2.86E-02	2	1.43	+	1.40	6.56E-01
response to ketone (GO:1901654)	207	4	1.14	+	3.52	2.86E-02	7	1.43	+	4.90	6.94E-04
cellular response to transforming growth factor beta stimulus (GO:0071560)	156	3	.86	+	3.50	5.65E-02	4	1.08	+	3.72	2.44E-02
cellular response to steroid hormone stimulus (GO:0071383)	156	3	.86	+	3.50	5.65E-02	4	1.08	+	3.72	2.44E-02
response to oxygen levels (GO:0070482)	314	6	1.72	+	3.48	8.27E-03	6	2.17	+	2.77	2.31E-02
regulation of protein catabolic process (GO:0042176)	369	7	2.03	+	3.46	4.59E-03	4	2.54	+	1.57	3.28E-01
cellular response to molecule of bacterial origin (GO:0071219)	211	4	1.16	+	3.45	3.03E-02	4	1.46	+	2.75	6.06E-02
negative regulation of response to external stimulus (GO:0032102)	423	8	2.32	+	3.45	2.52E-03	7	2.92	+	2.40	2.88E-02
defense response to other organism (GO:0098542)	1008	19	5.53	+	3.43	2.80E-06	12	6.95	+	1.73	7.45E-02
glycolipid metabolic process (GO:0006664)	107	2	.59	+	3.41	1.20E-01	4	.74	+	5.42	7.18E-03
non-membrane-bounded organelle assembly (GO:0140694)	322	6	1.77	+	3.40	9.27E-03	4	2.22	+	1.80	2.90E-01
response to lipopolysaccharide (GO:0032496)	324	6	1.78	+	3.37	9.53E-03	5	2.23	+	2.24	7.62E-02
liposaccharide metabolic process (GO:1903509)	108	2	.59	+	3.37	1.21E-01	4	.74	+	5.37	7.41E-03
homeostasis of number of cells (GO:0048872)	271	5	1.49	+	3.36	1.78E-02	4	1.87	+	2.14	1.21E-01
response to transforming growth factor beta (GO:0071559)	163	3	.89	+	3.35	6.26E-02	4	1.12	+	3.56	2.80E-02
organic hydroxy compound metabolic process (GO:1901615)	489	9	2.68	+	3.35	1.64E-03	7	3.37	+	2.08	8.65E-02
negative regulation of defense response (GO:0031348)	272	5	1.49	+	3.35	1.80E-02	4	1.88	+	2.13	1.22E-01
positive regulation of protein catabolic process (GO:0045732)	218	4	1.20	+	3.34	3.35E-02	2	1.50	+	1.33	6.65E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	274	5	1.50	+	3.32	1.85E-02	4	1.89	+	2.12	1.24E-01
alcohol metabolic process (GO:0006066)	330	6	1.81	+	3.31	1.04E-02	5	2.28	+	2.20	8.08E-02
cellular detoxification (GO:1990748)	110	2	.60	+	3.31	1.25E-01	6	.76	+	7.91	1.49E-04
negative regulation of kinase activity (GO:0033673)	222	4	1.22	+	3.28	3.54E-02	2	1.53	+	1.31	6.68E-01
carbohydrate catabolic process (GO:0016052)	112	2	.61	+	3.25	1.29E-01	3	.77	+	3.88	4.46E-02
epithelial cell apoptotic process (GO:1904019)	56	1	.31	+	3.25	2.68E-01	3	.39	+	7.77	7.73E-03
response to peptide (GO:1901652)	454	8	2.49	+	3.21	3.85E-03	11	3.13	+	3.51	3.67E-04
response to molecule of bacterial origin (GO:0002237)	342	6	1.88	+	3.20	1.22E-02	5	2.36	+	2.12	9.06E-02
negative regulation of apoptotic signaling pathway (GO:2001234)	229	4	1.26	+	3.18	3.89E-02	5	1.58	+	3.17	2.26E-02
regulation of leukocyte migration (GO:0002685)	229	4	1.26	+	3.18	3.89E-02	3	1.58	+	1.90	2.13E-01
innate immune response (GO:0045087)	760	13	4.17	+	3.12	3.06E-04	7	5.24	+	1.34	3.73E-01
cellular response to inorganic substance (GO:0071241)	235	4	1.29	+	3.10	4.21E-02	1	1.62	-	.62	1.00E00
negative regulation of apoptotic process (GO:0043066)	892	15	4.90	+	3.06	1.23E-04	17	6.15	+	2.76	1.65E-04
cellular response to biotic stimulus (GO:0071216)	238	4	1.31	+	3.06	4.37E-02	4	1.64	+	2.44	8.51E-02
cellular response to toxic substance (GO:0097237)	119	2	.65	+	3.06	1.42E-01	6	.82	+	7.31	2.23E-04
positive regulation of binding (GO:0051099)	179	3	.98	+	3.05	7.78E-02	6	1.23	+	4.86	1.75E-03
response to other organism (GO:0051707)	1373	23	7.54	+	3.05	1.57E-06	17	9.47	+	1.80	1.76E-02
response to external biotic stimulus (GO:0043207)	1376	23	7.55	+	3.05	1.63E-06	17	9.49	+	1.79	1.78E-02
regulation of protein serine/threonine kinase activity (GO:0071900)	359	6	1.97	+	3.05	1.51E-02	7	2.48	+	2.83	1.32E-02
response to inorganic substance (GO:0010035)	539	9	2.96	+	3.04	3.12E-03	10	3.72	+	2.69	4.60E-03
positive regulation of wound healing (GO:0090303)	60	1	.33	+	3.04	2.84E-01	3	.41	+	7.25	9.26E-03
negative regulation of immune system process (GO:0002683)	481	8	2.64	+	3.03	5.39E-03	7	3.32	+	2.11	5.11E-02
phospholipid biosynthetic process (GO:0008654)	245	4	1.34	+	2.97	4.77E-02	4	1.69	+	2.37	9.22E-02
negative regulation of programmed cell death (GO:0043069)	920	15	5.05	+	2.97	1.71E-04	17	6.35	+	2.68	2.36E-04
DNA recombination (GO:0006310)	247	4	1.36	+	2.95	4.88E-02	4	1.70	+	2.35	9.42E-02
response to biotic stimulus (GO:0009607)	1421	23	7.80	+	2.95	2.78E-06	17	9.80	+	1.73	2.88E-02
cellular response to peptide (GO:1901653)	309	5	1.70	+	2.95	2.90E-02	6	2.13	+	2.82	2.15E-02
regulation of leukocyte cell-cell adhesion (GO:1903037)	371	6	2.04	+	2.95	1.74E-02	5	2.56	+	1.95	1.17E-01
nucleocytoplasmic transport (GO:0006913)	248	4	1.36	+	2.94	4.94E-02	1	1.71	-	.58	1.00E00
nuclear transport (GO:0051169)	248	4	1.36	+	2.94	4.94E-02	1	1.71	-	.58	1.00E00
response to metal ion (GO:0010038)	372	6	2.04	+	2.94	1.76E-02	6	2.57	+	2.34	4.60E-02
negative regulation of proteolysis (GO:0045861)	314	5	1.72	+	2.90	3.07E-02	6	2.17	+	2.77	2.31E-02
regulation of carbohydrate metabolic process (GO:0006109)	189	3	1.04	+	2.89	8.80E-02	4	1.30	+	3.07	4.39E-02
regulation of T cell activation (GO:0050863)	379	6	2.08	+	2.88	1.91E-02	5	2.61	+	1.91	1.94E-01
epithelial cell differentiation (GO:0030855)	635	10	3.49	+	2.87	2.81E-03	5	4.38	+	1.14	6.29E-01
cognition (GO:0050890)	321	5	1.76	+	2.84	3.33E-02	3	2.21	+	1.36	4.89E-01
positive regulation of cell-cell adhesion (GO:0022409)	323	5	1.77	+	2.82	3.40E-02	6	2.23	+	2.69	2.60E-02
biological process involved in interspecies interaction between organisms (GO:0044419)	1553	24	8.52	+	2.82	3.57E-06	18	10.71	+	1.68	3.62E-02
defense response (GO:0006952)	1431	22	7.85	+	2.80	1.07E-05	18	9.87	+	1.82	1.25E-02
cellular response to lipid (GO:0071396)	527	8	2.89	+	2.77	9.06E-03	10	3.63	+	2.75	3.94E-03
positive regulation of lymphocyte activation (GO:0051251)	330	5	1.81	+	2.76	3.67E-02	5	2.28	+	2.20	8.08E-02
alpha-amino acid biosynthetic process (GO:1901607)	66	1	.36	+	2.76	3.07E-01	4	.46	+	8.79	1.36E-03
alpha-amino acid metabolic process (GO:1901605)	200	3	1.10	+	2.73	9.98E-02	6	1.38	+	4.35	2.99E-03
regulation of protein binding (GO:0043393)	202	3	1.11	+	2.71	1.02E-01	7	1.39	+	5.02	6.04E-04
chaperone-mediated protein folding (GO:0061077)	68	1	.37	+	2.68	3.15E-01	3	.47	+	6.40	1.28E-02
cell migration (GO:0016477)	892	13	4.90	+	2.66	1.32E-03	11	6.15	+	1.79	5.94E-02
response to bacterium (GO:0009617)	688	10	3.78	+	2.65	4.90E-03	9	4.75	+	1.90	5.83E-02
establishment of protein localization to organelle (GO:0072594)	344	5	1.89	+	2.65	4.26E-02	6	2.37	+	2.53	3.37E-02
membrane lipid metabolic process (GO:0006643)	207	3	1.14	+	2.64	1.08E-01	6	1.43	+	4.20	3.53E-03
carboxylic acid biosynthetic process (GO:0046394)	277	4	1.52	+	2.63	6.81E-02	8	1.91	+	4.19	7.93E-04
aromatic compound catabolic process (GO:0019439)	347	5	1.90	+	2.63	4.39E-02	4	2.39	+	1.67	3.08E-01
detoxification (GO:0098754)	139	2	.76	+	2.62	1.80E-01	6	.96	+	6.26	4.95E-04
regulation of body fluid levels (GO:0050878)	350	5	1.92	+	2.60	4.52E-02	7	2.41	+	2.90	1.16E-02
selective autophagy (GO:0061912)	70	1	.38	+	2.60	3.22E-01	3	.48	+	6.21	1.38E-02
organic acid biosynthetic process (GO:0016053)	280	4	1.54	+	2.60	7.03E-02	8	1.93	+	4.14	8.48E-04
positive regulation of immune response (GO:0050778)	633	9	3.47	+	2.59	8.59E-03	7	4.37	+	1.60	2.14E-01
negative regulation of protein metabolic process (GO:0051248)	986	14	5.41	+	2.59	1.10E-03	13	6.80	+	1.91	2.70E-02
cellular lipid metabolic process (GO:0044255)	918	13	5.04	+	2.58	1.70E-03	16	6.33	+	2.53	6.77E-04
positive regulation of response to wounding (GO:1903036)	71	1	.39	+	2.57	3.26E-01	4	.49	+	8.17	1.76E-03
regulation of smooth muscle cell proliferation (GO:0048660)	142	2	.78	+	2.57	1.86E-01	4	.98	+	4.08	1.81E-02
immune response (GO:0006955)	1649	23	9.05	+	2.54	3.03E-05	16	11.37	+	1.41	1.61E-01
negative regulation of endopeptidase activity (GO:0010951)	144	2	.79	+	2.53	1.90E-01	4	.99	+	4.03	1.90E-02
regulation of lymphocyte activation (GO:0051249)	504	7	2.77	+	2.53	2.20E-02	7	3.48	+	2.01	9.08E-02
response to steroid hormone (GO:0048545)	289	4	1.59	+	2.52	7.68E-02	7	1.99	+	3.51	4.36E-03
regulation of cell cycle phase transition (GO:1901987)	434	6	2.38	+	2.52	3.37E-02	3	2.99	+	1.00	1.00E00
negative regulation of peptidase activity (GO:0010466)	218	3	1.20	+	2.51	1.20E-01	5	1.50	+	3.33	1.88E-02
response to oxidative stress (GO:0006979)	367	5	2.01	+	2.48	5.33E-02	8	2.53	+	3.16	4.37E-03
regulation of apoptotic process (GO:0042981)	1471	20	8.07	+	2.48	1.53E-04	21	10.15	+	2.07	1.55E-03
regulation of coagulation (GO:0050818)	74	1	.41	+	2.46	3.37E-01	3	.51	+	5.88	1.59E-02
regulation of binding (GO:0051098)	371	5	2.04	+	2.46	5.53E-02	9	2.56	+	3.52	1.25E-03
response to mechanical stimulus (GO:0009612)	223	3	1.22	+	2.45	1.26E-01	5	1.54	+	3.25	2.05E-02
response to peptide hormone (GO:0043434)	373	5	2.05	+	2.44	5.63E-02	6	2.57	+	2.33	4.65E-02
monocarboxylic acid metabolic process (GO:0032787)	523	7	2.87	+	2.44	2.62E-02	13	3.61	+	3.60	8.32E-05
apoptotic process (GO:0006915)	1047	14	5.75	+	2.44	1.91E-03	15	7.22	+	2.08	6.79E-03
glutamine family amino acid metabolic process (GO:0009064)	75	1	.41	+	2.43	3.41E-01	3	.52	+	5.80	1.65E-02
positive regulation of immune system process (GO:0002684)	977	13	5.36	+	2.42	2.90E-03	10	6.74	+	1.48	2.29E-01
lipid biosynthetic process (GO:0008610)	606	8	3.33	+	2.41	1.93E-02	8	4.18	+	1.91	7.46E-02
positive regulation of leukocyte activation (GO:0002696)	379	5	2.08	+	2.40	5.95E-02	6	2.61	+	2.30	4.95E-02
response to organonitrogen compound (GO:0010243)	986	13	5.41	+	2.40	3.14E-03	14	6.80	+	2.06	9.66E-03
regulation of programmed cell death (GO:0043067)	1521	20	8.35	+	2.40	2.37E-04	21	10.49	+	2.00	3.18E-03
positive regulation of cell migration (GO:0030335)	534	7	2.93	+	2.39	2.89E-02	5	3.68	+	1.36	4.23E-01
cellular response to oxygen-containing compound (GO:1901701)	1146	15	6.29	+	2.38	1.61E-03	17	7.90	+	2.15	2.82E-03
regulation of protein kinase activity (GO:0045859)	615	8	3.38	+	2.37	2.09E-02	9	4.24	+	2.12	4.09E-02
regulation of epithelial cell differentiation (GO:0030856)	154	2	.85	+	2.37	2.09E-01	4	1.06	+	3.77	2.35E-02
cellular component morphogenesis (GO:0032989)	619	8	3.40	+	2.35	2.16E-02	4	4.27	-	.94	1.00E00
behavior (GO:0007610)	622	8	3.41	+	2.34	2.22E-02	6	4.29	+	1.40	3.30E-01
regulation of catabolic process (GO:0009894)	1013	13	5.56	+	2.34	3.93E-03	10	6.99	+	1.43	2.40E-01
programmed cell death (GO:0012501)	1093	14	6.00	+	2.33	2.82E-03	15	7.54	+	1.99	1.27E-02
response to toxic substance (GO:0009636)	235	3	1.29	+	2.33	1.41E-01	7	1.62	+	4.32	1.42E-03
negative regulation of catalytic activity (GO:0043086)	630	8	3.46	+	2.31	2.37E-02	8	4.35	+	1.84	8.41E-02
epithelium development (GO:0060429)	1103	14	6.05	+	2.31	4.92E-03	10	7.61	+	1.31	3.48E-01
cell death (GO:0008219)	1105	14	6.06	+	2.31	4.95E-03	15	7.62	+	1.97	1.33E-02
immune effector process (GO:0002252)	474	6	2.60	+	2.31	4.80E-02	6	3.27	+	1.84	1.48E-01
regulation of response to biotic stimulus (GO:0002831)	478	6	2.62	+	2.29	4.96E-02	6	3.30	+	1.82	1.50E-01
cellular response to growth factor stimulus (GO:0071363)	479	6	2.63	+	2.28	5.00E-02	7	3.30	+	2.12	5.02E-02
positive regulation of cell motility (GO:2000147)	559	7	3.07	+	2.28	3.56E-02	5	3.86	+	1.30	4.42E-01
inflammatory response (GO:0006954)	560	7	3.07	+	2.28	3.59E-02	9	3.86	+	2.33	1.66E-02
response to oxygen-containing compound (GO:1901700)	1681	21	9.23	+	2.28	3.83E-04	26	11.59	+	2.24	9.36E-05
anatomical structure formation involved in morphogenesis (GO:0048646)	961	12	5.27	+	2.28	1.11E-02	9	6.63	+	1.36	3.17E-01
amide metabolic process (GO:0043603)	801	10	4.40	+	2.27	1.33E-02	14	5.52	+	2.53	1.44E-03
cellular response to cytokine stimulus (GO:0071345)	721	9	3.96	+	2.27	1.85E-02	10	4.97	+	2.01	3.50E-02
anatomical structure homeostasis (GO:0060249)	241	3	1.32	+	2.27	1.49E-01	5	1.66	+	3.01	2.73E-02
tissue homeostasis (GO:0001894)	241	3	1.32	+	2.27	1.49E-01	5	1.66	+	3.01	2.73E-02
cell activation (GO:0001775)	724	9	3.97	+	2.26	1.90E-02	7	4.99	+	1.40	3.54E-01
regulation of immune response (GO:0050776)	889	11	4.88	+	2.25	1.02E-02	9	6.13	+	1.47	2.15E-01
protein localization to organelle (GO:0033365)	731	9	4.01	+	2.24	2.01E-02	8	5.04	+	1.59	1.71E-01
cell motility (GO:0048870)	1057	13	5.80	+	2.24	8.02E-03	12	7.29	+	1.65	8.39E-02
immune system process (GO:0002376)	2277	28	12.50	+	2.24	3.56E-05	21	15.70	+	1.34	1.78E-01
response to nitrogen compound (GO:1901698)	1060	13	5.82	+	2.23	8.11E-03	14	7.31	+	1.92	2.01E-02
fatty acid metabolic process (GO:0006631)	327	4	1.79	+	2.23	1.08E-01	6	2.26	+	2.66	2.73E-02
positive regulation of locomotion (GO:0040017)	575	7	3.16	+	2.22	4.04E-02	5	3.97	+	1.26	6.03E-01
regulation of immune system process (GO:0002682)	1488	18	8.17	+	2.20	1.50E-03	17	10.26	+	1.66	4.87E-02
tissue development (GO:0009888)	1753	21	9.62	+	2.18	6.00E-04	18	12.09	+	1.49	9.48E-02
cellular response to organic cyclic compound (GO:0071407)	502	6	2.76	+	2.18	5.99E-02	8	3.46	+	2.31	2.44E-02
cellular response to organonitrogen compound (GO:0071417)	593	7	3.25	+	2.15	4.63E-02	8	4.09	+	1.96	7.01E-02
supramolecular fiber organization (GO:0097435)	593	7	3.25	+	2.15	4.63E-02	6	4.09	+	1.47	3.09E-01
regulation of cell migration (GO:0030334)	933	11	5.12	+	2.15	1.92E-02	11	6.43	+	1.71	1.00E-01
multicellular organismal-level homeostasis (GO:0048871)	594	7	3.26	+	2.15	4.66E-02	9	4.10	+	2.20	2.32E-02
DNA damage response (GO:0006974)	766	9	4.20	+	2.14	3.93E-02	9	5.28	+	1.70	1.14E-01
regulation of leukocyte activation (GO:0002694)	596	7	3.27	+	2.14	4.73E-02	8	4.11	+	1.95	7.11E-02
response to lipid (GO:0033993)	854	10	4.69	+	2.13	2.78E-02	15	5.89	+	2.55	9.27E-04
leukocyte activation (GO:0045321)	601	7	3.30	+	2.12	4.91E-02	5	4.15	+	1.21	6.13E-01
response to abiotic stimulus (GO:0009628)	1118	13	6.14	+	2.12	1.04E-02	13	7.71	+	1.69	6.14E-02
response to endogenous stimulus (GO:0009719)	1464	17	8.03	+	2.12	2.98E-03	20	10.10	+	1.98	4.59E-03
response to organic substance (GO:0010033)	2592	30	14.23	+	2.11	8.41E-05	34	17.88	+	1.90	1.96E-04
response to external stimulus (GO:0009605)	2422	28	13.29	+	2.11	1.11E-04	30	16.70	+	1.80	1.51E-03
response to xenobiotic stimulus (GO:0009410)	433	5	2.38	+	2.10	9.20E-02	7	2.99	+	2.34	3.21E-02
carbohydrate derivative catabolic process (GO:1901136)	174	2	.95	+	2.09	2.50E-01	4	1.20	+	3.33	3.42E-02
negative regulation of intracellular signal transduction (GO:1902532)	524	6	2.88	+	2.09	7.04E-02	8	3.61	+	2.21	3.03E-02
response to stress (GO:0006950)	3424	39	18.79	+	2.08	5.45E-06	44	23.61	+	1.86	2.34E-05
response to hormone (GO:0009725)	791	9	4.34	+	2.07	4.26E-02	13	5.46	+	2.38	3.58E-03
regulation of response to external stimulus (GO:0032101)	1062	12	5.83	+	2.06	1.67E-02	13	7.32	+	1.77	5.31E-02
regulation of kinase activity (GO:0043549)	709	8	3.89	+	2.06	6.11E-02	10	4.89	+	2.05	3.29E-02
cellular response to stress (GO:0033554)	1603	18	8.80	+	2.05	3.98E-03	22	11.06	+	1.99	2.35E-03
cellular oxidant detoxification (GO:0098869)	90	1	.49	+	2.02	3.93E-01	5	.62	+	8.06	4.96E-04
positive regulation of protein binding (GO:0032092)	90	1	.49	+	2.02	3.93E-01	5	.62	+	8.06	4.96E-04
regulation of cell motility (GO:2000145)	991	11	5.44	+	2.02	2.47E-02	11	6.83	+	1.61	1.13E-01
regulation of hormone levels (GO:0010817)	542	6	2.97	+	2.02	1.28E-01	9	3.74	+	2.41	1.37E-02
response to cytokine (GO:0034097)	819	9	4.49	+	2.00	4.72E-02	10	5.65	+	1.77	7.98E-02
immunoglobulin mediated immune response (GO:0016064)	182	2	1.00	+	2.00	2.66E-01	4	1.26	+	3.19	3.92E-02
mitochondrion organization (GO:0007005)	458	5	2.51	+	1.99	1.10E-01	7	3.16	+	2.22	4.12E-02
small molecule biosynthetic process (GO:0044283)	461	5	2.53	+	1.98	1.12E-01	11	3.18	+	3.46	4.16E-04
cellular response to endogenous stimulus (GO:0071495)	1201	13	6.59	+	1.97	2.37E-02	16	8.28	+	1.93	1.10E-02
protein tetramerization (GO:0051262)	93	1	.51	+	1.96	4.03E-01	3	.64	+	4.68	2.83E-02
small molecule metabolic process (GO:0044281)	1676	18	9.20	+	1.96	5.38E-03	28	11.56	+	2.42	1.63E-05
organonitrogen compound catabolic process (GO:1901565)	1118	12	6.14	+	1.96	3.35E-02	14	7.71	+	1.82	3.79E-02
rhythmic process (GO:0048511)	280	3	1.54	+	1.95	2.01E-01	7	1.93	+	3.62	3.68E-03
carboxylic acid metabolic process (GO:0019752)	841	9	4.62	+	1.95	5.17E-02	18	5.80	+	3.10	2.42E-05
B cell mediated immunity (GO:0019724)	187	2	1.03	+	1.95	2.76E-01	4	1.29	+	3.10	4.26E-02
cellular response to organic substance (GO:0071310)	1777	19	9.75	+	1.95	6.20E-03	21	12.26	+	1.71	1.55E-02
regulation of apoptotic signaling pathway (GO:2001233)	375	4	2.06	+	1.94	1.53E-01	6	2.59	+	2.32	4.75E-02
regulation of locomotion (GO:0040012)	1036	11	5.69	+	1.93	3.07E-02	11	7.15	+	1.54	1.72E-01
biosynthetic process (GO:0009058)	2648	28	14.53	+	1.93	5.89E-04	39	18.26	+	2.14	3.62E-06
lipid metabolic process (GO:0006629)	1230	13	6.75	+	1.93	2.54E-02	18	8.48	+	2.12	3.67E-03
regulation of protein metabolic process (GO:0051246)	2462	26	13.51	+	1.92	1.14E-03	30	16.98	+	1.77	1.74E-03
amino acid metabolic process (GO:0006520)	285	3	1.56	+	1.92	2.08E-01	8	1.97	+	4.07	9.48E-04
macromolecule biosynthetic process (GO:0009059)	1526	16	8.38	+	1.91	1.11E-02	17	10.52	+	1.62	5.17E-02
negative regulation of cell projection organization (GO:0031345)	191	2	1.05	+	1.91	2.84E-01	5	1.32	+	3.80	1.13E-02
organic substance biosynthetic process (GO:1901576)	2585	27	14.19	+	1.90	8.99E-04	37	17.83	+	2.08	1.84E-05
cellular response to chemical stimulus (GO:0070887)	2397	25	13.16	+	1.90	1.69E-03	30	16.53	+	1.81	1.42E-03
oxoacid metabolic process (GO:0043436)	863	9	4.74	+	1.90	5.68E-02	18	5.95	+	3.02	3.37E-05
organonitrogen compound biosynthetic process (GO:1901566)	1348	14	7.40	+	1.89	2.03E-02	18	9.30	+	1.94	9.42E-03
organic acid metabolic process (GO:0006082)	870	9	4.77	+	1.88	5.86E-02	18	6.00	+	3.00	3.74E-05
transforming growth factor beta receptor signaling pathway (GO:0007179)	97	1	.53	+	1.88	4.16E-01	3	.67	+	4.48	3.14E-02
cellular lipid catabolic process (GO:0044242)	194	2	1.06	+	1.88	2.90E-01	4	1.34	+	2.99	4.75E-02
negative regulation of cell adhesion (GO:0007162)	292	3	1.60	+	1.87	2.18E-01	6	2.01	+	2.98	1.69E-02
negative regulation of molecular function (GO:0044092)	975	10	5.35	+	1.87	6.96E-02	12	6.72	+	1.78	4.65E-02
regulation of cell adhesion (GO:0030155)	789	8	4.33	+	1.85	8.20E-02	11	5.44	+	2.02	2.55E-02
regulation of hemopoiesis (GO:1903706)	403	4	2.21	+	1.81	2.88E-01	7	2.78	+	2.52	2.30E-02
cellular biosynthetic process (GO:0044249)	2228	22	12.23	+	1.80	5.91E-03	32	15.37	+	2.08	6.08E-05
regulation of proteolysis (GO:0030162)	709	7	3.89	+	1.80	1.16E-01	11	4.89	+	2.25	1.73E-02
regulation of catalytic activity (GO:0050790)	1827	18	10.03	+	1.80	1.86E-02	20	12.60	+	1.59	3.74E-02
positive regulation of protein metabolic process (GO:0051247)	1425	14	7.82	+	1.79	3.78E-02	18	9.83	+	1.83	1.22E-02
response to extracellular stimulus (GO:0009991)	509	5	2.79	+	1.79	2.08E-01	13	3.51	+	3.70	6.37E-05
regulation of peptidase activity (GO:0052547)	408	4	2.24	+	1.79	2.91E-01	7	2.81	+	2.49	2.44E-02
negative regulation of angiogenesis (GO:0016525)	102	1	.56	+	1.79	4.32E-01	3	.70	+	4.26	3.56E-02
regulation of glucose metabolic process (GO:0010906)	102	1	.56	+	1.79	4.32E-01	3	.70	+	4.26	3.56E-02
cellular nitrogen compound biosynthetic process (GO:0044271)	1633	16	8.96	+	1.79	2.20E-02	22	11.26	+	1.95	2.63E-03
negative regulation of response to stimulus (GO:0048585)	1637	16	8.98	+	1.78	2.23E-02	18	11.29	+	1.59	4.35E-02
negative regulation of blood vessel morphogenesis (GO:2000181)	103	1	.57	+	1.77	4.35E-01	3	.71	+	4.22	3.64E-02
regulation of protein modification process (GO:0031399)	1443	14	7.92	+	1.77	3.92E-02	18	9.95	+	1.81	1.32E-02
organic cyclic compound biosynthetic process (GO:1901362)	1239	12	6.80	+	1.76	4.74E-02	14	8.55	+	1.64	7.34E-02
negative regulation of vasculature development (GO:1901343)	104	1	.57	+	1.75	4.38E-01	3	.72	+	4.18	3.73E-02
regulation of phosphorylation (GO:0042325)	1170	11	6.42	+	1.71	9.80E-02	14	8.07	+	1.73	4.34E-02
negative regulation of hydrolase activity (GO:0051346)	320	3	1.76	+	1.71	2.59E-01	6	2.21	+	2.72	2.50E-02
phosphate-containing compound metabolic process (GO:0006796)	1817	17	9.97	+	1.70	2.91E-02	16	12.53	+	1.28	2.98E-01
cellular catabolic process (GO:0044248)	1076	10	5.91	+	1.69	8.93E-02	14	7.42	+	1.89	2.16E-02
phosphorus metabolic process (GO:0006793)	1843	17	10.12	+	1.68	3.10E-02	17	12.71	+	1.34	2.36E-01
response to organic cyclic compound (GO:0014070)	871	8	4.78	+	1.67	1.52E-01	14	6.01	+	2.33	3.06E-03
positive regulation of response to stimulus (GO:0048584)	2203	20	12.09	+	1.65	2.18E-02	22	15.19	+	1.45	7.57E-02
catabolic process (GO:0009056)	1983	18	10.88	+	1.65	3.57E-02	26	13.68	+	1.90	1.46E-03
carbohydrate metabolic process (GO:0005975)	449	4	2.46	+	1.62	3.17E-01	7	3.10	+	2.26	3.78E-02
multicellular organism development (GO:0007275)	3966	35	21.77	+	1.61	2.70E-03	36	27.35	+	1.32	7.00E-02
organic substance catabolic process (GO:1901575)	1709	15	9.38	+	1.60	6.08E-02	20	11.79	+	1.70	2.08E-02
cellular response to nutrient levels (GO:0031669)	229	2	1.26	+	1.59	3.60E-01	8	1.58	+	5.07	2.34E-04
response to chemical (GO:0042221)	3899	34	21.40	+	1.59	5.24E-03	43	26.89	+	1.60	1.18E-03
cellular component assembly (GO:0022607)	2418	21	13.27	+	1.58	3.86E-02	20	16.68	+	1.20	3.61E-01
organonitrogen compound metabolic process (GO:1901564)	4857	42	26.66	+	1.58	1.20E-03	51	33.50	+	1.52	1.00E-03
positive regulation of protein modification process (GO:0031401)	935	8	5.13	+	1.56	1.76E-01	12	6.45	+	1.86	3.96E-02
multicellular organismal process (GO:0032501)	6713	57	36.84	+	1.55	1.11E-04	56	46.30	+	1.21	8.82E-02
anatomical structure morphogenesis (GO:0009653)	2244	19	12.32	+	1.54	4.95E-02	20	15.48	+	1.29	2.24E-01
cell differentiation (GO:0030154)	3590	30	19.70	+	1.52	1.74E-02	31	24.76	+	1.25	1.82E-01
response to nutrient levels (GO:0031667)	479	4	2.63	+	1.52	3.40E-01	12	3.30	+	3.63	1.47E-04
cellular developmental process (GO:0048869)	3614	30	19.83	+	1.51	1.78E-02	31	24.93	+	1.24	1.84E-01
anatomical structure development (GO:0048856)	5201	43	28.54	+	1.51	3.16E-03	47	35.87	+	1.31	4.14E-02
cellular metabolic process (GO:0044237)	5828	48	31.99	+	1.50	1.55E-03	67	40.20	+	1.67	2.21E-06
animal organ development (GO:0048513)	2925	24	16.05	+	1.50	4.18E-02	26	20.17	+	1.29	1.83E-01
organelle organization (GO:0006996)	3060	25	16.79	+	1.49	4.54E-02	27	21.10	+	1.28	1.92E-01
system development (GO:0048731)	3553	29	19.50	+	1.49	2.41E-02	30	24.50	+	1.22	2.21E-01
regulation of epithelial cell proliferation (GO:0050678)	372	3	2.04	+	1.47	4.62E-01	9	2.57	+	3.51	1.27E-03
negative regulation of multicellular organismal process (GO:0051241)	1125	9	6.17	+	1.46	2.16E-01	17	7.76	+	2.19	2.43E-03
regulation of response to stimulus (GO:0048583)	3960	31	21.73	+	1.43	3.14E-02	34	27.31	+	1.24	1.65E-01
regulation of molecular function (GO:0065009)	2569	20	14.10	+	1.42	1.14E-01	30	17.72	+	1.69	4.66E-03
protein complex oligomerization (GO:0051259)	257	2	1.41	+	1.42	6.54E-01	6	1.77	+	3.39	9.61E-03
homeostatic process (GO:0042592)	1415	11	7.77	+	1.42	2.59E-01	17	9.76	+	1.74	2.84E-02
response to stimulus (GO:0050896)	8243	64	45.24	+	1.41	4.78E-04	74	56.85	+	1.30	4.42E-03
regulation of response to stress (GO:0080134)	1418	11	7.78	+	1.41	2.59E-01	17	9.78	+	1.74	2.86E-02
cellular response to extracellular stimulus (GO:0031668)	259	2	1.42	+	1.41	6.55E-01	9	1.79	+	5.04	9.86E-05
negative regulation of biological process (GO:0048519)	5320	41	29.20	+	1.40	1.73E-02	50	36.69	+	1.36	1.58E-02
nitrogen compound metabolic process (GO:0006807)	6614	50	36.30	+	1.38	8.34E-03	67	45.62	+	1.47	2.02E-04
positive regulation of biological process (GO:0048518)	6219	47	34.13	+	1.38	1.02E-02	55	42.89	+	1.28	3.45E-02
metabolic process (GO:0008152)	8086	61	44.38	+	1.37	1.88E-03	85	55.77	+	1.52	1.00E-06
developmental process (GO:0032502)	5702	43	31.29	+	1.37	1.99E-02	49	39.33	+	1.25	7.42E-02
positive regulation of cellular process (GO:0048522)	5511	41	30.25	+	1.36	2.54E-02	51	38.01	+	1.34	1.73E-02
primary metabolic process (GO:0044238)	7165	53	39.32	+	1.35	9.73E-03	72	49.42	+	1.46	1.28E-04
regulation of primary metabolic process (GO:0080090)	5825	43	31.97	+	1.35	2.74E-02	52	40.17	+	1.29	3.16E-02
organic substance metabolic process (GO:0071704)	7653	56	42.00	+	1.33	8.20E-03	78	52.78	+	1.48	2.41E-05
regulation of macromolecule metabolic process (GO:0060255)	6188	45	33.96	+	1.33	3.03E-02	54	42.68	+	1.27	4.33E-02
cellular response to stimulus (GO:0051716)	6472	47	35.52	+	1.32	2.51E-02	56	44.64	+	1.25	4.59E-02
regulation of nitrogen compound metabolic process (GO:0051171)	5646	41	30.99	+	1.32	4.40E-02	51	38.94	+	1.31	2.96E-02
regulation of cell development (GO:0060284)	829	6	4.55	+	1.32	4.66E-01	13	5.72	+	2.27	7.97E-03
response to glucose (GO:0009749)	139	1	.76	+	1.31	5.36E-01	5	.96	+	5.22	3.16E-03
regulation of metabolic process (GO:0019222)	6719	48	36.88	+	1.30	3.41E-02	59	46.34	+	1.27	3.08E-02
negative regulation of epithelial cell proliferation (GO:0050680)	140	1	.77	+	1.30	5.39E-01	4	.97	+	4.14	1.73E-02
regulation of multicellular organismal development (GO:2000026)	1401	10	7.69	+	1.30	3.50E-01	17	9.66	+	1.76	2.76E-02
positive regulation of macromolecule metabolic process (GO:0010604)	3514	25	19.29	+	1.30	1.67E-01	34	24.24	+	1.40	3.37E-02
negative regulation of cellular process (GO:0048523)	4705	33	25.82	+	1.28	1.16E-01	44	32.45	+	1.36	2.70E-02
response to hexose (GO:0009746)	144	1	.79	+	1.27	5.49E-01	5	.99	+	5.03	3.65E-03
regulation of vasculature development (GO:1901342)	291	2	1.60	+	1.25	6.76E-01	6	2.01	+	2.99	1.67E-02
cellular process (GO:0009987)	14672	100	80.53	+	1.24	1.54E-05	123	101.19	+	1.22	2.26E-05
regulation of multicellular organismal process (GO:0051239)	2983	20	16.37	+	1.22	3.47E-01	32	20.57	+	1.56	1.14E-02
regulation of neuron projection development (GO:0010975)	450	3	2.47	+	1.21	7.40E-01	7	3.10	+	2.26	3.81E-02
response to monosaccharide (GO:0034284)	152	1	.83	+	1.20	5.69E-01	5	1.05	+	4.77	4.56E-03
regulation of biological quality (GO:0065008)	2934	19	16.10	+	1.18	4.19E-01	30	20.24	+	1.48	2.93E-02
regulation of growth (GO:0040008)	624	4	3.42	+	1.17	5.88E-01	9	4.30	+	2.09	4.24E-02
biological regulation (GO:0065007)	12228	78	67.11	+	1.16	4.32E-02	95	84.34	+	1.13	7.20E-02
positive regulation of cell population proliferation (GO:0008284)	950	6	5.21	+	1.15	6.51E-01	12	6.55	+	1.83	4.19E-02
cell adhesion (GO:0007155)	967	6	5.31	+	1.13	6.56E-01	12	6.67	+	1.80	4.50E-02
cellular response to external stimulus (GO:0071496)	328	2	1.80	+	1.11	7.02E-01	9	2.26	+	3.98	5.36E-04
biological_process (GO:0008150)	17812	108	97.76	+	1.10	3.22E-03	135	122.85	+	1.10	1.77E-03
regulation of cell population proliferation (GO:0042127)	1674	10	9.19	+	1.09	7.30E-01	21	11.55	+	1.82	8.00E-03
hemopoiesis (GO:0030097)	685	4	3.76	+	1.06	7.91E-01	11	4.72	+	2.33	8.49E-03
cellular response to starvation (GO:0009267)	173	1	.95	+	1.05	6.16E-01	7	1.19	+	5.87	2.46E-04
epithelial cell proliferation (GO:0050673)	174	1	.95	+	1.05	6.18E-01	4	1.20	+	3.33	3.42E-02
cellular response to tumor necrosis factor (GO:0071356)	179	1	.98	+	1.02	6.28E-01	4	1.23	+	3.24	3.73E-02
response to carbohydrate (GO:0009743)	180	1	.99	+	1.01	1.00E00	5	1.24	+	4.03	8.99E-03
cell-substrate adhesion (GO:0031589)	185	1	1.02	-	.98	1.00E00	4	1.28	+	3.13	4.12E-02
monosaccharide metabolic process (GO:0005996)	192	1	1.05	-	.95	1.00E00	4	1.32	+	3.02	4.60E-02
negative regulation of neuron death (GO:1901215)	195	1	1.07	-	.93	1.00E00	4	1.34	+	2.97	4.82E-02
leukocyte differentiation (GO:0002521)	424	2	2.33	-	.86	1.00E00	7	2.92	+	2.39	2.91E-02
response to starvation (GO:0042594)	213	1	1.17	-	.86	1.00E00	7	1.47	+	4.77	8.16E-04
regulation of plasma membrane bounded cell projection organization (GO:0120035)	643	3	3.53	-	.85	1.00E00	9	4.43	+	2.03	4.62E-02
regulation of cell projection organization (GO:0031344)	657	3	3.61	-	.83	1.00E00	9	4.53	+	1.99	4.95E-02
negative regulation of cell migration (GO:0030336)	286	1	1.57	-	.64	1.00E00	6	1.97	+	3.04	1.54E-02
negative regulation of cell motility (GO:2000146)	301	1	1.65	-	.61	1.00E00	6	2.08	+	2.89	1.93E-02
negative regulation of locomotion (GO:0040013)	338	1	1.86	-	.54	1.00E00	6	2.33	+	2.57	3.13E-02
Unclassified (UNCLASSIFIED)	2777	5	15.24	-	.33	3.22E-03	7	19.15	-	.37	1.77E-03
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
regulation of dendritic cell antigen processing and presentation (GO:0002604)	11	0	.06	-	 < 0.01	1.00E00	2	.08	+	26.36	3.46E-03
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
regulation of antigen processing and presentation (GO:0002577)	20	0	.11	-	 < 0.01	1.00E00	2	.14	+	14.50	9.84E-03
positive regulation of myeloid cell differentiation (GO:0045639)	102	0	.56	-	 < 0.01	1.00E00	3	.70	+	4.26	3.56E-02
galactolipid catabolic process (GO:0019376)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
negative regulation of endothelial cell proliferation (GO:0001937)	43	0	.24	-	 < 0.01	1.00E00	2	.30	+	6.74	3.81E-02
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
metanephric mesenchymal cell differentiation (GO:0072162)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
kidney mesenchymal cell proliferation (GO:0072135)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
negative regulation of receptor catabolic process (GO:2000645)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of MHC class I biosynthetic process (GO:0045345)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
carnitine biosynthetic process (GO:0045329)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
negative regulation of endothelial cell chemotaxis (GO:2001027)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
amino-acid betaine biosynthetic process (GO:0006578)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
zinc ion import across plasma membrane (GO:0071578)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
glutamine biosynthetic process (GO:0006542)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
asparagine biosynthetic process (GO:0006529)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
asparagine metabolic process (GO:0006528)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
metaphase/anaphase transition of cell cycle (GO:0044784)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
positive regulation of protein kinase B signaling (GO:0051897)	113	0	.62	-	 < 0.01	1.00E00	4	.78	+	5.13	8.61E-03
regulation of protein kinase B signaling (GO:0051896)	167	0	.92	-	 < 0.01	1.00E00	4	1.15	+	3.47	3.02E-02
reduction of food intake in response to dietary excess (GO:0002023)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
error-free translesion synthesis (GO:0070987)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
L-asparagine metabolic process (GO:0070982)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
L-asparagine biosynthetic process (GO:0070981)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
termination of mitochondrial transcription (GO:0006393)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
medium-chain fatty acid biosynthetic process (GO:0051792)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
short-chain fatty acid biosynthetic process (GO:0051790)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
double-strand break repair via nonhomologous end joining (GO:0006303)	44	0	.24	-	 < 0.01	1.00E00	2	.30	+	6.59	3.96E-02
glutathione derivative biosynthetic process (GO:1901687)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
glutathione derivative metabolic process (GO:1901685)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
double-strand break repair via single-strand annealing (GO:0045002)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
response to progesterone (GO:0032570)	40	0	.22	-	 < 0.01	1.00E00	2	.28	+	7.25	3.36E-02
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	14	0	.08	-	 < 0.01	1.00E00	2	.10	+	20.71	5.25E-03
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
cellular response to cobalt ion (GO:0071279)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
maintenance of mitochondrion location (GO:0051659)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
cell-cell adhesion in response to extracellular stimulus (GO:0140039)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
positive regulation of intracellular cholesterol transport (GO:0032385)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
positive regulation of intracellular sterol transport (GO:0032382)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
positive regulation of intracellular lipid transport (GO:0032379)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
glycolytic process (GO:0006096)	45	0	.25	-	 < 0.01	1.00E00	2	.31	+	6.44	4.12E-02
gluconeogenesis (GO:0006094)	49	0	.27	-	 < 0.01	1.00E00	2	.34	+	5.92	4.78E-02
amino sugar metabolic process (GO:0006040)	42	0	.23	-	 < 0.01	1.00E00	2	.29	+	6.90	3.65E-02
DNA double-strand break processing (GO:0000729)	19	0	.10	-	 < 0.01	1.00E00	2	.13	+	15.26	8.98E-03
regulation of atrial cardiac muscle cell action potential (GO:0098910)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of AV node cell action potential (GO:0098904)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
negative regulation of kidney development (GO:0090185)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
regulation of kidney development (GO:0090183)	36	0	.20	-	 < 0.01	1.00E00	2	.25	+	8.06	2.79E-02
cadmium ion transmembrane transport (GO:0070574)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
dimethylallyl diphosphate metabolic process (GO:0050993)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
dimethylallyl diphosphate biosynthetic process (GO:0050992)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
positive regulation of plasma membrane repair (GO:1905686)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
abscission (GO:0009838)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
regulation of acyl-CoA biosynthetic process (GO:0050812)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
positive regulation of the force of heart contraction (GO:0098735)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
negative regulation of cold-induced thermogenesis (GO:0120163)	47	0	.26	-	 < 0.01	1.00E00	2	.32	+	6.17	4.44E-02
negative regulation of translation in response to stress (GO:0032055)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	35	0	.19	-	 < 0.01	1.00E00	2	.24	+	8.29	2.65E-02
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
cell-abiotic substrate adhesion (GO:0036164)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
calcium-mediated signaling using intracellular calcium source (GO:0035584)	23	0	.13	-	 < 0.01	1.00E00	2	.16	+	12.61	1.26E-02
positive regulation of metallopeptidase activity (GO:1905050)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
isopentenyl diphosphate biosynthetic process (GO:0009240)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
positive regulation of lipophagy (GO:1904504)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
regulation of lipophagy (GO:1904502)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
manganese ion homeostasis (GO:0055071)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
double-strand break repair via classical nonhomologous end joining (GO:0097680)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
positive regulation of lipoprotein particle clearance (GO:0010986)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
aspartate family amino acid biosynthetic process (GO:0009067)	21	0	.12	-	 < 0.01	1.00E00	2	.14	+	13.81	1.07E-02
aspartate family amino acid metabolic process (GO:0009066)	48	0	.26	-	 < 0.01	1.00E00	2	.33	+	6.04	4.61E-02
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
negative regulation of cell-substrate adhesion (GO:0010812)	60	0	.33	-	 < 0.01	1.00E00	3	.41	+	7.25	9.26E-03
cadmium ion transport (GO:0015691)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
viral capsid secondary envelopment (GO:0046745)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
fructosamine catabolic process (GO:0030392)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
fructosamine metabolic process (GO:0030389)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of serine C-palmitoyltransferase activity (GO:1904220)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
regulation of fatty acid biosynthetic process (GO:0042304)	45	0	.25	-	 < 0.01	1.00E00	2	.31	+	6.44	4.12E-02
regulation of plasminogen activation (GO:0010755)	18	0	.10	-	 < 0.01	1.00E00	2	.12	+	16.11	8.16E-03
negative regulation of cGMP-mediated signaling (GO:0010754)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
cardiac neuron differentiation (GO:0060945)	1	0	.01	-	 < 0.01	1.00E00	1	.01	+	 > 100	1.37E-02
negative regulation of epithelial cell migration (GO:0010633)	68	0	.37	-	 < 0.01	1.00E00	3	.47	+	6.40	1.28E-02
negative regulation of transcription by transcription factor localization (GO:0010621)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
regulation of sprouting angiogenesis (GO:1903670)	37	0	.20	-	 < 0.01	1.00E00	2	.26	+	7.84	2.93E-02
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
cellular response to glucose starvation (GO:0042149)	49	0	.27	-	 < 0.01	1.00E00	2	.34	+	5.92	4.78E-02
negative regulation of mature B cell apoptotic process (GO:0002906)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
regulation of mature B cell apoptotic process (GO:0002905)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
negative regulation of protein localization to cilium (GO:1903565)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
nitrogen utilization (GO:0019740)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	6	0	.03	-	 < 0.01	1.00E00	1	.04	+	24.17	4.70E-02
isopentenyl diphosphate metabolic process (GO:0046490)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
ammonia assimilation cycle (GO:0019676)	2	0	.01	-	 < 0.01	1.00E00	1	.01	+	72.50	2.04E-02
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	4	0	.02	-	 < 0.01	1.00E00	1	.03	+	36.25	3.38E-02
type B pancreatic cell apoptotic process (GO:0097050)	3	0	.02	-	 < 0.01	1.00E00	1	.02	+	48.33	2.71E-02
L-methionine salvage from methylthioadenosine (GO:0019509)	5	0	.03	-	 < 0.01	1.00E00	1	.03	+	29.00	4.04E-02
